Expanding the Clinical Utility of HER2 as a Multi-Tumor Target, Overcoming Resistance Mechanisms & Optimizing Pharmacology of Next Generation
Anti-HER2 Drugs
The momentum in anti-HER2 drug development is impossible to ignore:
The astonishing successes that are Herceptin and Enhertu have demonstrated what the gold standard looks like for ADCs and immunotherapy alike in Breast cancer. Selecting HER2 as your target of choice is a wise decision; however, ongoing challenges with heterogeneity, therapeutic resistance and limited provable efficacy outside of breast cancer are preventing these powerful therapies from achieving similar success in other disease areas.
This is the one-stop-shop for all challenges HER2. Tackle the challenges at the heart of treating HER2-expressing breast cancer and non-breast tumors. Overcome the development challenges to advance therapeutics of all varieties quickly through your pipeline, ADCs, immunotherapies, and radiopharmaceuticals alike.
Accompanying you from preclinical through to post approval indication agnostic trials, this meeting has been designed to enable the field to expand the clinical utility of HER2 as a multi-tumor target with a multiple modality approach and an aspiration to push beyond the boundaries of breast cancer.
Top Highlights you won't want to miss in 2023:
Explore the next generation, novel drug modalities targeting HER2 including ADCs, bispecifics, TKIs, CAR and cancer vaccine approaches in early clinical development
Investigate HER2 pathology in the HER2 low, HER2 mutant and HER2 amplified settings across indications spanning from breast to colon, biliary tract, lung cancer and more
Rationalize combination approaches and crack the sequencing conundrum to attach brain metastases and overcome resistance mechanisms
Target HER2 with precision and apply personalized assays through learnings from innovative basket clinical trial designs
Examine the competitive HER2 therapeutic landscape to understand impacts on pricing, commercialization and patient access
Download the Full Event Guide for more information on:
- 20+ Expert Speaker Faculty
- Interactive workshops
- Full access to the 3-day conference agenda
- & more
